SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-039200
Filing Date
2022-06-24
Accepted
2022-06-24 16:05:39
Documents
2
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3982
2 POA DOCUMENT poa.txt EX-24 4373
  Complete submission text file 0001209191-22-039200.txt   9811
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STRET WALTHAM MA 02451
Business Address
Martin John Richard (Reporting) CIK: 0001715152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 221040054